Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | POLB | P06746 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | BLM | P54132 | 3/20 | 0.40 |
| ▸ | PKM | P14618 | 2/20 | 0.40 |
| ▸ | CASP1 | P29466 | 2/20 | 0.40 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.40 |
| ▸ | RECQL | P46063 | 2/20 | 0.40 |
| ▸ | CASP7 | P55210 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1176634 | 0.80 | ALDH1A1 (0.38) | KDM4EALDH1A1POLBMAPTHSD17B10 | |
| SCHEMBL26545868 | 0.78 | ALDH1A1 (0.33) | KDM4EALDH1A1POLBMAPTHSD17B10 | |
| SCHEMBL9770023 | 0.73 | KDM4E (0.35) | KDM4EALDH1A1POLBMAPTHSD17B10 | |
| SCHEMBL22750936 | 0.71 | HSD17B10 (0.67) | KDM4EALDH1A1POLBMAPTHSD17B10 | |
| SCHEMBL2885259 | 0.71 | — | — | |
| SCHEMBL13638238 | 0.69 | ALDH1A1 (0.39) | KDM4EALDH1A1POLBMAPTHSD17B10 | |
| Benzene SCHEMBL27953403 | 0.69 | — | — | |
| SCHEMBL1406996 | 0.68 | GABRA1 (0.38) | HPGDBLML3MBTL1LMNATSHR | |
| SCHEMBL315517 | 0.68 | — | — | |
| SCHEMBL1799678 | 0.68 | ALDH1A1 (0.63) | KDM4EALDH1A1POLBMAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230302142-A1 | Cytotoxic Agents | Pheon Therapeutics Ltd. (GB) | 2023-09-28 | — | — | US | disclosed |
| US-20190355911-A1 | ORGANIC MIXTURE, ORGANIC COMPOSITION, ORGANIC ELECTRONIC COMPONENT AND PREPARATION METHOD THEREFOR | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2019-11-21 | — | — | US | disclosed |
| US-20190330152-A1 | FUSED RING COMPOUND, HIGH POLYMER, MIXTURE, COMPOSITION, AND ORGANIC ELECTRONIC COMPONENT | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2019-10-31 | — | — | US | disclosed |
| CN-101466810-B | Adhesive composition, method for producing same, and adhesive body | JSR CORP | 2011-04-27 | — | — | CN | disclosed |
| CN-101466810-A | Adhesive composition, method for producing same, and adhesive body | JSR CORP (JP) | 2009-06-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190330152-A1 | FUSED RING COMPOUND, HIGH POLYMER, MIXTURE, COMPOSITION, AND ORGANIC ELECTRONIC COMPONENT | EED, OCIAD2, OCIAD1 | KDM4E 1195/4885ALDH1A1 1299/4885POLB 1800/4885 |
| US-20230302142-A1 | Cytotoxic Agents | ANXA11, ANXA5, HAX1 | KDM4E 4140/4885ALDH1A1 3438/4885POLB 1962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.